脂质纳米载体作为脑瘤的精密传递系统
Roshan Keshari1, Mahima Dewani1, Navneet Kaur2,3
1Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai 400076, India.
Bioconjugate chemistry
|February 12, 2025
概括
脂质纳米粒子 (LNP) 为脑瘤治疗提供了一个有前途的解决方案,克服了血脑屏障 (BBB) 和当前治疗的局限性. 这些纳米载体增强药物输送,减少副作用,并为个性化脑癌疗法铺平道路.
科学领域:
- 纳米医学是一种纳米医学.
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 大脑瘤,特别是质母细胞瘤,由于侵入性和血脑屏障 (BBB) 具有挑战性.
- 传统的治疗方法 (放射治疗,化疗,免疫治疗) 面临诸如副作用,耐药性和脑透能力差等局限性.
研究的目的:
- 分析脂质纳米颗粒 (LNP) 用于脑瘤治疗的设计,机制和治疗益处.
- 讨论在神经瘤学中与LNP相关的安全性,临床发展和挑战.
主要方法:
- 对LNP设计和在脑瘤治疗中的应用现有文献的审查和分析.
- 讨论LNP属性,如药物封装,受控释放,生物相容性和BBB交叉能力.
主要成果:
- 临床核蛋白显示出作为针对脑瘤的向传递系统的潜力,克服了BBB的局限性.
- 临床药物提供优势,包括多重药物加载,受控释放和改善生物相容性.
结论:
- 在脑瘤治疗方面,LNP代表了显著的进步,提供有针对性的治疗和减少副作用.
- 工程LNP可以克服生物障碍,从而实现个性化,更安全,更实惠的脑癌治疗方案.
更多相关视频
07:25Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
Published on: March 1, 2024
1.7K
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
2.4K
相关概念视频
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...